JD LLB - Intelgenx Technologs VP Counsel
IGXT Stock | USD 0.17 0.00 0.00% |
Insider
JD LLB is VP Counsel of Intelgenx Technologs
Age | 35 |
Phone | 514 331 7440 |
Web | https://www.intelgenx.com |
Intelgenx Technologs Management Efficiency
The company has return on total asset (ROA) of (0.367) % which means that it has lost $0.367 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.2896) %, meaning that it created substantial loss on money invested by shareholders. Intelgenx Technologs' management efficiency ratios could be used to measure how well Intelgenx Technologs manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Julie Bockenstette | Acumen Pharmaceuticals | N/A | |
Yuemei Yan | Ascletis Pharma | 53 | |
Deepika PharmD | Pmv Pharmaceuticals | 48 | |
MBA MD | Monopar Therapeutics | 38 | |
David Mack | Pmv Pharmaceuticals | 62 | |
George Hill | Ascletis Pharma | 72 | |
W Vernon | Nuvation Bio | 65 | |
CPA CPA | Acurx Pharmaceuticals LLC | 57 | |
Winston MBA | Pmv Pharmaceuticals | 48 | |
James CPA | Eton Pharmaceuticals | 52 | |
Ming CPA | Ascletis Pharma | N/A | |
Nathan Caffo | Candel Therapeutics | 55 | |
FMEDSCI MD | Candel Therapeutics | 62 | |
Jeffrey Bornstein | Eledon Pharmaceuticals | N/A | |
Sergey Yurasov | Nuvation Bio | 51 | |
Carrie Cox | Candel Therapeutics | 66 | |
Russell MS | Acumen Pharmaceuticals | 66 | |
Francesca MD | Candel Therapeutics | 46 | |
Janice Hitchcock | Acumen Pharmaceuticals | N/A | |
Gregory Flesher | Eledon Pharmaceuticals | 54 | |
Kathryn Falberg | Nuvation Bio | 60 |
Management Performance
Return On Equity | -5.29 | |||
Return On Asset | -0.37 |
Intelgenx Technologs Leadership Team
Elected by the shareholders, the Intelgenx Technologs' board of directors comprises two types of representatives: Intelgenx Technologs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intelgenx. The board's role is to monitor Intelgenx Technologs' management team and ensure that shareholders' interests are well served. Intelgenx Technologs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intelgenx Technologs' outside directors are responsible for providing unbiased perspectives on the board's policies.
Stephen Kilmer, Investor Officer | ||
JD LLB, VP Counsel | ||
Ingrid Zerbe, Director - Finance and Administration, Corporate Secretary | ||
Nadine Paiement, Vice President - Research & Development | ||
Horst Zerbe, Founder, Chairman, CEO and Pres |
Intelgenx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Intelgenx Technologs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -5.29 | |||
Return On Asset | -0.37 | |||
Operating Margin | (7.39) % | |||
Current Valuation | 30.97 M | |||
Shares Outstanding | 174.65 M | |||
Shares Owned By Insiders | 22.64 % | |||
Price To Earning | (55.38) X | |||
Price To Book | 11.54 X | |||
Price To Sales | 19.11 X | |||
Revenue | 1.53 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Intelgenx Pink Sheet Analysis
When running Intelgenx Technologs' price analysis, check to measure Intelgenx Technologs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelgenx Technologs is operating at the current time. Most of Intelgenx Technologs' value examination focuses on studying past and present price action to predict the probability of Intelgenx Technologs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelgenx Technologs' price. Additionally, you may evaluate how the addition of Intelgenx Technologs to your portfolios can decrease your overall portfolio volatility.